Latest
MBSB BANK INTRODUCES TERM INVESTMENT ACCOUNT FOR SMES WITH 3.8% P.A. CAMPAIGN RATE FOR 12-MONTH TENURE
Friday, 15 May 2026 5:11PM 
MBSB Bank empowers SMEs with flexible placements, returns up to 3.80% p.a., and a low RM5,000 entry....
See MoreJohor Plantations Group Delivers Solid 1QFY2026 Operational Performance and Pricing Premium with Revenue Rising to RM356.7 Million
Friday, 15 May 2026 4:24PM
JOHOR BAHRU, May 15 (Bernama) -- Johor Plantations Group Berhad (JPG or the Group) recorded rev...
See MoreOther Press Release
Hytera's 5G Body Camera To Revolutionize Digital Evidence Acquisition And Management
Thursday, 24 Oct 2024 12:00AM
New Smart SC Series Body Camera (Photo: Business Wire) SHENZHEN, China, Oct 24 (Bernama-BUSINES...
See MoreEBC Financial Group 扩大与 DiNapoli 领先指标的合作伙伴关系，揭示应对黑天鹅事件的关键策略
Thursday, 24 Oct 2024 12:00AM
台北，台湾, Oct 24 (Bernama-GLOBE NEWSWIRE) -- EBC Financial Group (EB...
See MoreNTIS MARKS 3 YEARS OF EMPOWERING TECHNOLOGICAL GROWTH
Thursday, 24 Oct 2024 12:00AM
Opening Speech by YB. Dato' Haji Mohammad Yusof Bin ApdalDeputy Minister Of Science, Technology ...
See MoreOPUS International And HSS Engineering Forge Strategic Joint Venture To Lead Infrastructure Development Across Southeast Asia And Middle East
Wednesday, 23 Oct 2024 12:00AM
Ir. Sharifah Azlina Raja Kamal Pasmah, CEO, HSS Engineers Bhd and Tan Sri Ir. Kuna Sittampalam...
See MoreNIQ Launches Marketing Mix Modeling Solutions, Expanding Its Media Division
Wednesday, 23 Oct 2024 12:00AM
Best-In-Class Proprietary granular store level dataIndependent global expertise with local footprint...
See MoreHytera To Revolutionize Mobile Workforce Communication By Launching P5 Series PoC Radio
Wednesday, 23 Oct 2024 12:00AM
Hytera's newly released PoC P5 Series Radio (Graphic: Business Wire) SHENZHEN, China,...
See MoreJumio Leads With Innovation By Announcing Over 300 Patents And Patent Applications
Wednesday, 23 Oct 2024 12:00AM
(Graphic: Business Wire)Company’s expansive portfolio covers wide-ranging and advanced i...
See MoreRecursion Announces First Patient Dosed In Phase 2 Clinical Study Of REC-3964, A Potential First-in-class, Oral, Non-antibiotic Small Molecule For Recurrent Clostridioides Difficile Infection
Wednesday, 23 Oct 2024 12:00AM
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS.REC-3964 rep...
See More
Another project by BERNAMA Media Relations and Event Management (MREM)